Louisiana State Employees Retirement System’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6M Sell
29,300
-300
-1% -$133K 0.22% 59
2026
Q1
$13.2M Sell
29,600
-400
-1% -$187K 0.23% 53
2025
Q4
$13.6M Sell
30,000
-2,200
-7% -$948K 0.23% 58
2025
Q3
$12.6M Sell
32,200
-100
-0.3% -$41.8K 0.21% 63
2025
Q2
$14.4M Sell
32,300
-300
-0.9% -$138K 0.26% 55
2025
Q1
$15.8M Sell
32,600
-100
-0.3% -$46.6K 0.31% 41
2024
Q4
$13.2M Sell
32,700
-1,500
-4% -$695K 0.25% 49
2024
Q3
$15.9M Sell
34,200
-900
-3% -$432K 0.29% 42
2024
Q2
$16.5M Sell
35,100
-200
-0.6% -$86.8K 0.32% 44
2024
Q1
$14.8M Sell
35,300
-800
-2% -$338K 0.29% 49
2023
Q4
$14.7M Sell
36,100
-300
-0.8% -$111K 0.31% 46
2023
Q3
$12.7M Buy
36,400
+4,400
+14% +$1.54M 0.29% 49
2023
Q2
$11.3M Buy
32,000
+2,500
+8% +$842K 0.25% 60
2023
Q1
$9.29M Buy
29,500
+100
+0.3% +$30K 0.24% 69
2022
Q4
$8.49M Sell
29,400
-800
-3% -$244K 0.23% 71
2022
Q3
$8.74M Buy
30,200
+300
+1% +$86.3K 0.26% 62
2022
Q2
$8.66M Buy
29,900
+200
+0.7% +$53.5K 0.23% 70
2022
Q1
$8.47M Buy
29,700
+300
+1% +$71.2K 0.2% 80
2021
Q4
$6.46M Sell
29,400
-100
-0.3% -$19.4K 0.14% 105
2021
Q3
$5.35M Hold
29,500
0.13% 113
2021
Q2
$5.95M Hold
29,500
0.14% 103
2021
Q1
$6.34M Buy
29,500
+2,000
+7% +$439K 0.17% 93
2020
Q4
$6.5M Buy
27,500
+14,300
+108% +$3.28M 0.19% 84
2020
Q3
$3.59M Buy
13,200
+2,100
+19% +$579K 0.17% 86
2020
Q2
$3.22M Buy
11,100
+200
+2% +$54.2K 0.19% 78
2020
Q1
$2.59M Sell
10,900
-1,300
-11% -$298K 0.19% 84
2019
Q4
$2.67M Sell
12,200
-200
-2% -$40.5K 0.13% 118
2019
Q3
$2.1M Sell
12,400
-400
-3% -$70.8K 0.11% 164
2019
Q2
$2.25M Sell
12,800
-700
-5% -$122K 0.11% 155
2019
Q1
$2.48M Buy
13,500
+100
+0.7% +$18.5K 0.12% 132
2018
Q4
$2.22M Sell
13,400
-1,600
-11% -$277K 0.13% 131
2018
Q3
$2.89M Hold
15,000
0.12% 127
2018
Q2
$2.55M Sell
15,000
-500
-3% -$77.5K 0.11% 145
2018
Q1
$2.53M Buy
15,500
+200
+1% +$32.7K 0.12% 144
2017
Q4
$2.29M Sell
15,300
-400
-3% -$59.2K 0.1% 165
2017
Q3
$2.39M Buy
15,700
+300
+2% +$45.2K 0.11% 153
2017
Q2
$1.99M Buy
15,400
+100
+0.7% +$12K 0.1% 190
2017
Q1
$1.67M Sell
15,300
-300
-2% -$26.4K 0.08% 234
2016
Q4
$1.15M Sell
15,600
-200
-1% -$16.3K 0.06% 401
2016
Q3
$1.38M Sell
15,800
-400
-2% -$37.8K 0.07% 298
2016
Q2
$1.39M Sell
16,200
-300
-2% -$25.9K 0.07% 289
2016
Q1
$1.31M Sell
16,500
-700
-4% -$63.3K 0.07% 327
2015
Q4
$2.16M Sell
17,200
-700
-4% -$84.5K 0.11% 157
2015
Q3
$1.86M Buy
17,900
+100
+0.6% +$12.8K 0.1% 195
2015
Q2
$2.2M Buy
17,800
+400
+2% +$50.4K 0.1% 172
2015
Q1
$2.05M Sell
17,400
-700
-4% -$83.9K 0.1% 188
2014
Q4
$2.15M Sell
18,100
-200
-1% -$22.5K 0.1% 180
2014
Q3
$2.06M Sell
18,300
-200
-1% -$19K 0.1% 182
2014
Q2
$1.75M Sell
18,500
-200
-1% -$14K 0.08% 252
2014
Q1
$1.32M Sell
18,700
-100
-0.5% -$7.92K 0.06% 372
2013
Q4
$1.4M Buy
+18,800
New +$1.31M 0.07% 332

Other funds holding VRTX

Louisiana State Employees Retirement System's VRTX Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its Vertex Pharmaceuticals (VRTX) stake by 1% in Q2 2026, selling an estimated $133K and leaving 29,300 shares worth $14.6M. The position accounts for 0.22% of the portfolio, ranked #59.

Louisiana State Employees Retirement System first reported a position in VRTX in Q4 2013 and has held it in 51 quarters since. The position peaked at $16.5M in Q2 2024. 589 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Louisiana State Employees Retirement System held 29,300 shares of Vertex Pharmaceuticals worth $14.6M as of Q2 2026.
  • Louisiana State Employees Retirement System sold 300 Vertex Pharmaceuticals shares in Q2 2026, an estimated $133K.
  • Vertex Pharmaceuticals made up 0.22% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #59 holding.
  • Louisiana State Employees Retirement System first reported a position in Vertex Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
  • Louisiana State Employees Retirement System's Vertex Pharmaceuticals position peaked at $16.5M in Q2 2024.
  • 589 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.